Pharmacokinetics and safety of inhaled oxytocin compared with intramuscular oxytocin in women in the third stage of labour: A randomized open‐label study
British Journal of Clinical Pharmacology · 2023
DOI: 10.1111/bcp.15860 ↗Kurz gefasst
Klinische Studie (Phase I) in der Zeitschrift British Journal of Clinical Pharmacology, 2023. Verfasst von Katarzyna Gajewska-Knapik und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. Hauptthemen laut MEDLINE: Oxytocics, Postpartum Hemorrhage. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: GSK Plc, GlaxoSmithKline.
Abstract (Originalsprache)
Aims
To compare pharmacokinetics (PK) and safety of heat‐stable inhaled (IH) oxytocin with intramuscular (IM) oxytocin in women in third stage of labour (TSL), the primary endpoint being PK profiles of oxytocin IH and secondary endpoint of safety.
Methods
A phase 1, randomized, cross‐over study was undertaken in 2 UK and 1 Australian centres. Subjects were recruited into 2 groups: Group 1, women in TSL; Group 2, nonpregnant women of childbearing potential (Cohort A, combined oral contraception; Cohort B, nonhormonal contraception). Participants were randomized 1:1 to: Group 1, oxytocin 10 IU (17 μg) IM or oxytocin 240 IU (400 μg) IH immediately after delivery; Group 2, oxytocin 5 IU (8.5 μg) intravenously and oxytocin 240 IU (400 μg) IH at 2 separate dosing sessions.
Results
Participants were recruited between 23 November 2016 to 4 March 2019. In Group 1, 17 participants were randomized; received either IH ( n = 9) or IM ( n = 8) oxytocin. After IH and IM administration, most plasma oxytocin concentrations were below quantification limits (2 pg/mL). In Group 2 ( n = 14), oxytocin IH concentrations remained quantifiable ≤3 h postdose. Adverse events were reported in both groups, with no deaths reported: Group 1, IH n = 3 (33%) and IM n = 2 (25%); Group 2, n = 14 (100%).
Conclusion
Safety profiles of oxytocin IH and IM were similar. However, PK profiles could not be established for oxytocin IH or IM in women in TSL, despite using a highly sensitive and specific assay.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynaecology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
- GSK, London, UK.
- Department of Obstetrics and Gynaecology, Monash Medical Centre, Monash Health, Melbourne, Australia.
- GSK, Stevenage, UK.
- Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Australia.
- GSK Clinical Unit Cambridge, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
ORCID-Profile: Carl Kirkpatrick
Förderung
- GSK Plc
- GlaxoSmithKline
Zitieren
APA
Gajewska-Knapik, K., Kumar, S., Sutton-Cole, A., Palmer, K. R., Cahn, A., Gibson, R. A., Kirkpatrick, C., Parry, S., Schneider, I., Siederer, S., Stylianou, A., Hacquoil, K., Powell, M., Ellis, M., McIntosh, M. P., & Lambert, P. (2023). Pharmacokinetics and safety of inhaled oxytocin compared with intramuscular oxytocin in women in the third stage of labour: A randomized open‐label study. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.15860
Vancouver
Gajewska-Knapik K, Kumar S, Sutton-Cole A, Palmer KR, Cahn A, Gibson RA, et al. Pharmacokinetics and safety of inhaled oxytocin compared with intramuscular oxytocin in women in the third stage of labour: A randomized open‐label study. British Journal of Clinical Pharmacology. 2023. doi:10.1111/bcp.15860
BibTeX
@article{GajewskaKnapik2023,
author = {Gajewska-Knapik, Katarzyna and Kumar, Subramanya and Sutton-Cole, Amy and Palmer, Kirsten R and Cahn, Anthony and Gibson, Rachel A and Kirkpatrick, Carl and Parry, Simon and Schneider, Ian and Siederer, Sarah and Stylianou, Annie and Hacquoil, Kimberley and Powell, Marcy and Ellis, Melissa and McIntosh, Michelle P and Lambert, Pete},
title = {Pharmacokinetics and safety of inhaled oxytocin compared with intramuscular oxytocin in women in the third stage of labour: A randomized open‐label study},
journal = {British Journal of Clinical Pharmacology},
year = {2023},
doi = {10.1111/bcp.15860}
}
EUVIMED